D L Birx - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D L Birx

Showing results (11-20 of 99) with videos related to

Pageof 10

Sort By:

The New England Journal of Medicine|April 3, 1986

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disordersD L Birx, R R Redfield, G Tosato

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984

The interference of T cell activation by calcium channel blocking agentsD L Birx, M Berger, T A Fleisher

Nature Medicine|July 14, 1998

Vaccine reactionsJ R Mascola, J G McNeil, D L Birx

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1997

Dynamics of cell-free viral burden in HIV-1-infected patientsN L Michael, G Chang, J H Kim, et al.

Journal of Immunological Methods|February 5, 1992

Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1T C VanCott, L D Loomis, R R Redfield, et al.

Journal of Immunological Methods|June 14, 1995

Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogenT C VanCott, S C Veit, V Kalyanaraman, et al.

AIDS Research and Human Retroviruses|June 1, 1994

Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with a recombinant gp 160 subunit vaccine in a phase I studyM Vahey, D L Birx, N L Michael, et al.

The Journal of Infectious Diseases|March 9, 1999

Proliferative responses to human immunodeficiency virus type 1 (HIV-1) gp120 peptides in HIV-1-infected individuals immunized with HIV-1 rgp120 or rgp160 compared with nonimmunized and uninfected controlsK V Sitz, S Ratto-Kim, A S Hodgkins, et al.

Blood|December 1, 1990

Induction of interleukin-6 during human immunodeficiency virus infectionD L Birx, R R Redfield, K Tencer, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995

Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccinesT C VanCott, F R Bethke, D S Burke, et al.

Pageof 10

Search research articles

Showing results (11-20 of 99) with videos related to

Sort By:

Pageof 10

The New England Journal of Medicine|April 3, 1986

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disordersD L Birx, R R Redfield, G Tosato

Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1984

The interference of T cell activation by calcium channel blocking agentsD L Birx, M Berger, T A Fleisher

Nature Medicine|July 14, 1998

Vaccine reactionsJ R Mascola, J G McNeil, D L Birx

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1997

Dynamics of cell-free viral burden in HIV-1-infected patientsN L Michael, G Chang, J H Kim, et al.

Journal of Immunological Methods|February 5, 1992

Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1T C VanCott, L D Loomis, R R Redfield, et al.

Journal of Immunological Methods|June 14, 1995

Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogenT C VanCott, S C Veit, V Kalyanaraman, et al.

AIDS Research and Human Retroviruses|June 1, 1994

The Journal of Infectious Diseases|March 9, 1999

Blood|December 1, 1990

Induction of interleukin-6 during human immunodeficiency virus infectionD L Birx, R R Redfield, K Tencer, et al.

Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1995

Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccinesT C VanCott, F R Bethke, D S Burke, et al.

Pageof 10